Assembly Biosciences, Inc. Skyrocketed
Thu, Dec 12, 2019 at 05:30 PM
Assembly Biosciences, Inc. (ASMB:NASDAQ) shot up at $23.81, representing a gain of 34.4%. On Wed 11 Dec 19, ASMB:NASDAQ touched a New 2-Week High of $17.71. The stock got featured on our News Catalysts scanner on Thu 12 Dec 19 at 07:56 AM in the 'PUBLIC OFFERING' category. From Wed 20 Nov 19, the stock recorded 78.57% Up Days and 73.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Assembly Biosciences, Inc. (ASMB:NASDAQ)
Assembly Biosciences Inc is a clinical stage biotechnology company advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.
Top 10 Gainers:
- Assertio Therapeutics, Inc. (ASRT:NASDAQ), 56.65%
- Amneal Pharmaceuticals, Inc. (AMRX:NYSE), 44.83%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 44.67%
- Pacific Coast Oil Trust (ROYT:NYSE), 38.26%
- Assembly Biosciences, Inc. (ASMB:NASDAQ), 34.44%
- Ferroglobe PLC (GSM:NASDAQ), 32.6%
- LSC Communications, Inc. (LKSD:NYSE), 28.19%
- CTI BioPharma Corp. (CTIC:NASDAQ), 26.45%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 25.54%
- Top Ships Inc. (TOPS:NASDAQ), 24.48%